Angiographic characteristics of symptomatic recurrent disease after infrainguinal percutaneous transluminal angioplasty

Citation
Hk. Soder et al., Angiographic characteristics of symptomatic recurrent disease after infrainguinal percutaneous transluminal angioplasty, CARDIO IN R, 22(3), 1999, pp. 219-223
Citations number
24
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
ISSN journal
01741551 → ACNP
Volume
22
Issue
3
Year of publication
1999
Pages
219 - 223
Database
ISI
SICI code
0174-1551(199905/06)22:3<219:ACOSRD>2.0.ZU;2-Z
Abstract
Purpose: To evaluate the angiographic patterns of clinically manifest recur rent disease after infrainguinal percutaneous transluminal angioplasty (PTA ) of stenoses and total occlusions. Methods: Among 326 infrainguinal PTAs on 263 consecutive patients, selectiv e angiography was performed on 61 limbs of 52 patients 1-60 months after th e primary intervention because of clinically suspected recurrent disease. L esion-specific and patient-related factors were analyzed for 75 angiographi cally confirmed recurrent lesions in 57 limbs of 48 patients. Results: Recurrent disease was more frequently a stenosis when the original target lesion was a stenosis (92%, 44/48) than when the original lesion wa s a total occlusion (59%, 16/27; p < 0.001). When the original target lesio n was a stenosis, the total length of the recurrent disease was longer than that of the original lesion [3.9 +/- 3.9 cm (mean +/- standard deviation) vs 2.8 +/- 2.7 cm; p = 0.03], while in the subgroup of original total occlu sions the length of the recurrent lesion was shorter than that of the origi nal occlusion (7.1 +/- 5.0 cm vs 9.9 +/- 6.9 cm; p = 0.02). Half the resten oses (22/44) extended beyond one or both ends of the original stenosis and 38% (6/16) of the reocclusions ex tended beyond the distal end of the origi nal occlusion. Conclusions: The type of recurrent disease depends on the original lesion t ype and the restenotic lesion frequently extends beyond one or both ends of the original target lesion.